Re: USA ZHCLF investors
in response to
by
posted on
Oct 30, 2022 01:28PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
KBC - I don't remember the exact number but DM did say the financing was 80 something cents. On the RPS topic, you have it exactly correct. Koo, you are talking like individuals own the RPSs but they don't.
In the spinout, ZCC (not shareholders) received 75,202,620 RPS’s. They are not a ZCC security rather an RVX security own by the corporation ZCC. This number holds no significance within ZCC as royalties would be received according to a percentage of net profit within RVX, not as a monetary amount per RPS. The total amount earned as royalties would be paid into ZCC coffers and be a ZCC asset. All ZCC assets are owned collectively by each shareholder in proportion to their shareholdings. All ZHCLF shares and financing shares are ZCC shares so each holds its proportionate share of the existing ZCC assets. Each would receive the same amount of any dividend paid out from the royalties.